Clinical trial
A Serologic Study to Correlate Beta-IFN NAb Titers to Beta-IFN Induced Biomarker…
NCT00288990 · Biogen, Industry · Completed
Key facts
| NCT number | NCT00288990 |
|---|---|
| Title | A Serologic Study to Correlate Beta-IFN NAb Titers to Beta-IFN Induced Biomarker Response in Patients With Multiple Sclerosis |
| Official title | Impact of Neutralizing Antibodies on Interferon Responsive Genes Highlights Biomarker Response. |
| Lead sponsor | Biogen, Industry |
| Status | Completed |
| Study type | Observational |
| Conditions | Multiple Sclerosis |
| Enrollment | 300 |
| Start date | Jan 1, 2006 |
| Completion | Aug 1, 2007 |
| First posted | Feb 9, 2006 |
| Last update posted | Dec 24, 2007 |
| Countries | United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: